A systematic review of evidence on the association between cocaine use and seizures

Drug and Alcohol Dependence

Volumn 133, Issue 3, 2013, Pages 795-804

  Sordo, L ^a,b,c   Indave, B I ^d   Degenhardt, L ^e,f,g   Barrio, G ^h   Kaye, S ^e   Ruiz Perez I ^c,i   Bravo, M J ^a,c  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL DE MÓSTOLES   (Spain)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f BURNET INSTITUTE   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h INSTITUTO DE SALUD CARLOS III   (Spain)

ⁱ ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

Author keywords

Cocaine use; Neurologic disorder; Seizures; Systematic review

Indexed keywords

COCAINE;

CAUSAL ATTRIBUTION; COCAINE DEPENDENCE; DISEASE ASSOCIATION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SEIZURE; SYSTEMATIC REVIEW;

COCAINE USE; NEUROLOGIC DISORDER; SEIZURES; SYSTEMATIC REVIEW;

BRAIN; COCAINE; COCAINE-RELATED DISORDERS; HUMANS; SEIZURES;

EID: 84888432248     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.08.019     Document Type: Review

References (68)

1. Annegers J.F., Hauser W.A., Lee J.R., Rocca W.A. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995, 36:327-333.
2. Anta G.B., Rodriguez Arenas M.A., de la Fuente de Hoz, Royuela M.L. Emergency room admissions in cocaine users in Spanish hospitals: first evidences of acute complications related to crack use, Work Group for the Study of Emergencies from Psychostimulants. Med. Clin. (Barc.) 1998, 111:49-55.
3. Atkins D., Best D., Briss P.A., Eccles M., Falck-Ytter Y., Flottorp S., Guyatt G.H., Harbour R.T., Haugh M.C., Henry D., Hill S., Jaeschke R., Leng G., Liberati A., Magrini N., Mason J., Middleton P., Mrukowicz J., O'Connell D., Oxman A.D., Phillips B., Schunemann H.J., Edejer T., Varonen H., Vist G.E., Williams J.W., Zaza S. Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490.
4. Blaho K., Logan B., Winbery S., Park L., Schwilke E. Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am. J. Emerg. Med. 2000, 18:593-598.
5. Brody S.L., Slovis C.M., Wrenn K.D. Cocaine-related medical problems: consecutive series of 233 patients. Am. J. Med. 1990, 88:325-331.
6. Choy-Kwong M., Lipton R.B. Seizures in hospitalized cocaine users. Neurology 1989, 39:425-427.
7. Cregler L.L., Mark H. Medical complications of cocaine abuse. N. Engl. J. Med. 1986, 315:1495-1500.
8. Daras M. Neurologic complications of cocaine. NIDA Res. Monogr. 1996, 163:43-65.
9. Degenhardt L., Singleton J., Calabria B., McLaren J., Kerr T., Mehta S., Kirk G., Hall W.D. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011, 113:88-95.
10. Degenhardt L.J., Calabria B., Nelson P.K., Bucello C., Roberts A., Thomas J., Hall W.D. Methodology used in a systematic review of evidence on the prevalence of amphetamine use and dependence 2009, National Drug and Alcohol Research Centre, The University of New South Wales, Sydney, NSW, Available from: http://www.gbd.unsw.edu.au/gbdweb.nsf/resources/No+Attachment/file/Methodology+used+in+a+systematic+review+of+evidence+on+the+prevalence+of+ATS+use+and+dependence+-+discussion+paper.pdf (accessed on 10.19.12).
11. Derlet R.W., Albertson T.E. Emergency department presentation of cocaine intoxication. Ann. Emerg. Med. 1989, 18:182-186.
12. Devlin R.J., Henry J.A. Clinical review: major consequences of illicit drug consumption. Crit. Care 2008, 12:202.
13. Dherani M., Pope D., Mascarenhas M., Smith K.R., Weber M., Bruce N. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull. WHO 2008, 86:390-398.
14. Dhuna A., Pascual-Leone A., Langendorf F., Anderson D.C. Epileptogenic properties of cocaine in humans. Neurotoxicology 1991, 12:621-626.
15. Dohi T., Kitayama S., Morita K. Inhibition of monoamine neurotransmitter transporters and central nervous system stimulation induced by synthetic local anesthetics and cocaine: a comparative review. Curr. Med. Chem. - Central Nerv. Syst. Agents 2005, 5:89-100.
16. EMCDDA Cocaine and Crack Cocaine: A Growing Public Health Issue 2007, Available from: http://www.emcdda.europa.eu/html.cfm/index44746EN.html (accessed 03.03.13), European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.
17. Farooq M.U., Bhatt A., Patel M. Neurotoxic and cardiotoxic effects of cocaine and ethanol. J. Med. Toxicol. 2009, 5:134-138.
18. Ferri C.P., Dunn J., Gossop M., Laranjeira R. Factors associated with adverse reactions to cocaine among a sample of long-term, high-dose users in Sao Paulo, Brazil. Addict. Behav. 2004, 29:365-374.
19. Gomez A.M., Cuenca C.C., Farfan S.A., Villalba M.V., del Toro C.J., Garcia C.J. Complications of intestinal transporting of cocaine packets. Study of 215 cases. Med. Clin. (Barc.) 1998, 111:336-337.
20. Harbour R., Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001, 323:334-336.
21. Harden C.L., Daras M., Tuchman A.J. Cocaine causing convulsions in a large municipal hospital population. J. Epilepsy 1992, 5:175-177.
22. Hayase T., Yamamoto Y., Yamamoto K. Behavioral effects of ketamine and toxic interactions with psychostimulants. BMC Neurosci. 2006, 7:25.
23. Hoffman R.S., Smilkstein M.J., Goldfrank L.R. Whole bowel irrigation and the cocaine body-packer: a new approach to a common problem. Am. J. Emerg. Med. 1990, 8:523-527.
24. Kaminski R.M., Witkin J.M., Shippenberg T.S. Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling. Neuropharmacology 2007, 52:895-903.
25. Karler R., Petty C., Calder L., Turkanis S.A. Proconvulsant and anticonvulsant effects in mice of acute and chronic treatment with cocaine. Neuropharmacology 1989, 28:709-714.
26. Kaye S., Darke S. Injecting and non-injecting cocaine use in Sydney Australia: physical and psychological morbidity. Drug Alcohol Rev. 2004, 23:391-398.
27. Kiszka M. Cocaine toxicity. Arch. Med. Sadowej Kryminol. 2003, 53:151-166.
28. Klein C., Balash Y., Pollak L., Hiss J., Rabey M.J. Body packer: cocaine intoxication, causing death, masked by concomitant administration of major tranquilizers. Eur. J. Neurol. 2000, 7:555-558.
29. Koppel B.S., Samkoff L., Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia 1996, 37:875-878.
30. Leach J.P., Mohanraj R., Borland W. Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention. Epilepsia 2012, 53:48-57.
31. Lowenstein D.H. Seizures and epilepsy. Harrison's Principles Practices of Internal Medicine 2011, McGraw-Hill, New York.
32. Lowenstein D.H., Massa S.M., Rowbotham M.C., Collins S.D., McKinney H.E., Simon R.P. Acute neurologic and psychiatric complications associated with cocaine abuse. Am. J. Med. 1987, 83:841-846.
33. Macedo D.S., Santos R.S., Belchior L.D., Neto M.A., Vasconcelos S.M., Lima V.T., Fonteles M.M., Viana G.S., de Sousa F.C. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav. 2004, 5:852-856.
34. Meehan S.M., Schechter M.D. Cocaethylene-induced kindling of seizure effects: cross-specificity with cocaine. Pharmacol. Biochem. Behav. 1996, 54:491-494.
35. Meehan T.J., Bryant S.M., Aks S.E. Drugs of abuse: the highs and lows of altered mental states in the emergency department. Emerg. Med. Clin. North Am. 2010, 28:663-682.
36. Moak D.H., Anton R.F. Alcohol-related seizures and the kindling effect of repeated detoxifications: the influence of cocaine. Alcohol Alcohol. 1996, 31:135-143.
37. Morita K., Hamamoto M., Arai S., Kitayama S., Irifune M., Kawahara M., Kihira K., Dohi T. Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities. Brain Res. 2005, 1057:153-160.
38. Nakahara Y., Ishigami A. Inhalation efficiency of free-base cocaine by pyrolysis of 'crack' and cocaine hydrochloride. J. Anal. Toxicol. 1991, 15:105-109.
39. Ng S.K., Brust J.C., Hauser W.A., Susser M. Illicit drug use and the risk of new-onset seizures. Am. J. Epidemiol. 1990, 132:47-57.
40. O'Dell L.E., George F.R., Ritz M.C. Antidepressant drugs appear to enhance cocaine-induced toxicity. Exp. Clin. Psychopharmacol. 2000, 8:133-141.
41. O'Dell L.E., Kreifeldt M.J., George F.R., Ritz M.C. The role of serotonin(2) receptors in mediating cocaine-induced convulsions. Pharmacol. Biochem. Behav. 2000, 65:677-681.
42. Olson K.R., Kearney T.E., Dyer J.E., Benowitz N.L., Blanc P.D. Seizures associated with poisoning and drug overdose. Am. J. Emerg. Med. 1994, 12:392-395.
43. Pallin D.J., Goldstein J.N., Moussally J.S., Pelletier A.J., Green A.R., Camargo C.A. Seizure visits in US emergency departments: epidemiology and potential disparities in care. Int. J. Emerg. Med. 2008, 1:97-105.
44. Pascual-Leone A., Dhuna A., Altafullah I., Anderson D.C. Cocaine-induced seizures. Neurology 1990, 40:404-407.
45. Post R.M., Weiss S.R. Psychomotor stimulant vs. local anesthetic effects of cocaine: role of behavioral sensitization and kindling. NIDA Res. Monogr. 1988, 88:217-238.
46. Pulido J., Brugal M.T., de la Fuente L., Ballesta R., Barrio G., Bravo M.J., Domingo-Salvany A., Castellano Y., Fernandez F. Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the Itinere-cocaine Project). Gac. Sanit. 2009, 23:200-207.
47. Rich J.A., Singer D.E. Cocaine-related symptoms in patients presenting to an urban emergency department. Ann. Emerg. Med. 1991, 20:616-621.
48. Ritz M.C., George F.R. Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology (Berl.) 1997, 129:299-310.
49. Rolland B., Karila L., Geoffroy P.A., Cottencin O. Shared vulnerability between seizures and psychosis in cocaine addiction?. Epilepsy Behav. 2011, 22:596-598.
50. Roper A., Samuels M.A. Epilepsyand other seizures disorders. Adams and Victor's Principles of Neurology 2009, McGraw-Hill, New York.
51. Roussotte F., Soderberg L., Sowell E. Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging. Neuropsychol. Rev. 2010, 20:376-397.
52. SAMHSA Drug Abuse Warning Network, 2009: National Estimates of Drug-Related Emergency Department Visits, Substance Abuse and Mental Health Services Administration, DAWN Series D-35, HHS Publication No. (SMA) 11-4659. Rockville, MD 2011, Available from: http://www.samhsa.gov/data/2k11/dawn/2k9dawned/html/dawn2k9ed.htm (accessed 10.01.13).
53. Sanjurjo E., Montori E., Nogue S., Sanchez M., Munne P. Cocaine abuse attended in the emergency department: an emerging pathology. Med. Clin. (Barc.) 2006, 126:616-619.
54. Schwartz R.H., Luxenberg M.G., Hoffmann N.G. Crack use by American middle-class adolescent polydrug abusers. J. Pediatr. 1991, 118:150-155.
55. Scottish Intercollegiate Guidelines Network SIGN 50: A Guidelines Developers' Handbook 2011, Scottish Intercollegiate Guidelines Network, Edinburg, Available from: http://www.sign.ac.uk/pdf/sign50.pdf (accessed 10.01.13). Revised edition.
56. Signs S.A., Dickey-White H.I., Vanek V.W., Perch S., Schechter M.D., Kulics A.T. The formation of cocaethylene and clinical presentation of ED patients testing positive for the use of cocaine and ethanol. Am. J. Emerg. Med. 1996, 14:665-670.
57. Sopena B., Rivera A., Rodriguez-Dominguez M., Rodriguez-Rodriguez M., Argibay A., Maure B., Gimena B., Martinez-Vazquez C. Complications related with cocaine abuse that required hospital admission. Rev. Clin. Esp. 2008, 208:12-17.
58. Steele M.T., Westdorp E.J., Garza A.G., Ma O.J., Roberts D.K., Watson W.A. Screening for stimulant use in adult emergency department seizure patients. J. Toxicol. Clin. Toxicol. 2000, 38:609-613.
59. Thundiyil J.G., Kearney T.E., Olson K.R. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J. Med. Toxicol. 2007, 3:15-19.
60. Trask C.L., Kosofsky B.E. Developmental considerations of neurotoxic exposures. Neurol. Clin. 2000, 18:541-562.
61. UNODC World Drug Report 2013, United Nations Office on Drugs and Crime, United Nations publication, Vienna, Available from: http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf (accessed 06.07.13).
62. van Holst R.J., Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr. Drug Abuse Rev. 2011, 4:42-56.
63. Vitale S., van de Mheen D. Illicit drug use and injuries: a review of emergency room studies. Drug Alcohol Depend. 2006, 82:1-9.
64. Voss P.H., Rehfuess E.A. Quality appraisal in systematic reviews of public health interventions: an empirical study on the impact of choice of tool on meta-analysis. J. Epidemiol. Commun. Health 2013, 67:98-104.
65. Weiss R.D., Gawin F.H. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. Am. J. Med. 1988, 85:879-880.
66. Wells G., Shea B., O'Connell D., Peterson J., Welch V., Losos M., Tugwell P. Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. 3rd Symposium on Systematic Reviews: beyond the basics. Improving quality and impact 2000.
67. Witkin J.M., Baez M., Yu J., Barton M.E., Shannon H.E. Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholds. Epilepsy Res. 2007, 75:39-45.
68. Yeung M., Bhalla A., Birns J. Recreational drug misuse and stroke. Curr. Drug Abuse Rev. 2011, 4:286-291.